Ashley Albert1, Miriam A Knoll2, John A Conti3, Ross I S Zbar4. 1. Department of Radiation Oncology, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA. 2. Department of Radiation Oncology, John Theurer Cancer Center, an HMH-MSKCC partnership, 92 2nd St, Hackensack, NJ, 07601, USA. Miriam.knoll@hackensackmeridian.org. 3. Cancer Program, Hackensack Meridian Health Mountainside Medical Center, 1 Bay Avenue, Montclair, NJ, 07042, USA. 4. Division of Plastic Surgery, Hackensack Meridian Health Mountainside, 1 Bay Ave, Glen Ridge, NJ, 07028, USA.
Abstract
PURPOSE OF REVIEW: The incidence of non-melanomatous skin cancer (NMSC) increases with age and there are specific considerations regarding management of NMSC for the older patient population. Here we will review current data regarding treatment considerations and options for older patients with NMSC. RECENT FINDINGS: Hypofractionated regimens and high-dose brachytherapy may be non-surgical treatment options for older patients with NMSC. Other less aggressive strategies such as active surveillance can also be considered in some settings. Management of NMSC in the older patient population requires a thorough assessment of comorbidities, frailty, and life expectancy. Additionally, discussions regarding goals of care and quality of life (QOL) issues are especially important in this population. Older patients with NMSC in particular may benefit from a tailored treatment plan based on current available data rather than a broad application of general treatment guidelines for NMSC.
PURPOSE OF REVIEW: The incidence of non-melanomatous skin cancer (NMSC) increases with age and there are specific considerations regarding management of NMSC for the older patient population. Here we will review current data regarding treatment considerations and options for older patients with NMSC. RECENT FINDINGS: Hypofractionated regimens and high-dose brachytherapy may be non-surgical treatment options for older patients with NMSC. Other less aggressive strategies such as active surveillance can also be considered in some settings. Management of NMSC in the older patient population requires a thorough assessment of comorbidities, frailty, and life expectancy. Additionally, discussions regarding goals of care and quality of life (QOL) issues are especially important in this population. Older patients with NMSC in particular may benefit from a tailored treatment plan based on current available data rather than a broad application of general treatment guidelines for NMSC.
Authors: J G Chen; A B Fleischer; E D Smith; C Kancler; N D Goldman; P M Williford; S R Feldman Journal: Dermatol Surg Date: 2001-12 Impact factor: 3.398
Authors: Susan M Swetter; Jennifer C Boldrick; Peterson Pierre; Patricia Wong; Barbara M Egbert Journal: J Cutan Pathol Date: 2003-02 Impact factor: 1.587
Authors: John S Rhee; B Alex Matthews; Marcy Neuburg; Timothy L Smith; Mary Burzynski; Ann B Nattinger Journal: Arch Otolaryngol Head Neck Surg Date: 2004-02
Authors: Marjolijn S Haisma; Linda Bras; Mehran Alizadeh Aghdam; Jorrit B Terra; Boudewijn E C Plaat; Emöke Rácz; Gyorgy B Halmos Journal: Acta Derm Venereol Date: 2020-06-18 Impact factor: 3.875